Single-Molecule Super-Resolution Microscopy Reveals Heteromeric Complexes of MET and EGFR upon Ligand Activation.
Cell Line, Tumor
Cell Membrane
/ metabolism
Epidermal Growth Factor
/ pharmacology
ErbB Receptors
/ metabolism
HeLa Cells
Hepatocyte Growth Factor
/ pharmacology
Humans
Ligands
Multiprotein Complexes
/ metabolism
Proto-Oncogene Proteins c-met
/ metabolism
Signal Transduction
Single Molecule Imaging
/ methods
DNA-PAINT
EGFR
MET
receptor cross-interaction
receptor tyrosine kinases
single-molecule localization microscopy
single-particle tracking
Journal
International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791
Informations de publication
Date de publication:
17 Apr 2020
17 Apr 2020
Historique:
received:
20
01
2020
revised:
06
04
2020
accepted:
15
04
2020
entrez:
23
4
2020
pubmed:
23
4
2020
medline:
20
1
2021
Statut:
epublish
Résumé
Receptor tyrosine kinases (RTKs) orchestrate cell motility and differentiation. Deregulated RTKs may promote cancer and are prime targets for specific inhibitors. Increasing evidence indicates that resistance to inhibitor treatment involves receptor cross-interactions circumventing inhibition of one RTK by activating alternative signaling pathways. Here, we used single-molecule super-resolution microscopy to simultaneously visualize single MET and epidermal growth factor receptor (EGFR) clusters in two cancer cell lines, HeLa and BT-20, in fixed and living cells. We found heteromeric receptor clusters of EGFR and MET in both cell types, promoted by ligand activation. Single-protein tracking experiments in living cells revealed that both MET and EGFR respond to their cognate as well as non-cognate ligands by slower diffusion. In summary, for the first time, we present static as well as dynamic evidence of the presence of heteromeric clusters of MET and EGFR on the cell membrane that correlates with the relative surface expression levels of the two receptors.
Identifiants
pubmed: 32316583
pii: ijms21082803
doi: 10.3390/ijms21082803
pmc: PMC7215329
pii:
doi:
Substances chimiques
Ligands
0
Multiprotein Complexes
0
Epidermal Growth Factor
62229-50-9
Hepatocyte Growth Factor
67256-21-7
EGFR protein, human
EC 2.7.10.1
ErbB Receptors
EC 2.7.10.1
MET protein, human
EC 2.7.10.1
Proto-Oncogene Proteins c-met
EC 2.7.10.1
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : Volkswagen Foundation
ID : 91069
Organisme : Deutsche Forschungsgemeinschaft
ID : SFB1177
Organisme : Hessisches Ministerium für Wissenschaft und Kunst
ID : Ub-Net
Organisme : Hessisches Ministerium für Wissenschaft und Kunst
ID : DynaMem
Références
Nature. 2019 Mar;567(7748):305-307
pubmed: 30894741
Mol Reprod Dev. 2015 Jul-Aug;82(7-8):518-29
pubmed: 26153368
BMC Biophys. 2013 Jun 03;6(1):6
pubmed: 23731667
Phys Rev E Stat Nonlin Soft Matter Phys. 2010 Oct;82(4 Pt 1):041914
pubmed: 21230320
Nat Methods. 2019 Jul;16(7):565-566
pubmed: 31217592
Sci Rep. 2016 Oct 05;6:34486
pubmed: 27703238
Invest Ophthalmol Vis Sci. 2007 May;48(5):2242-8
pubmed: 17460286
Curr Opin Cell Biol. 2007 Apr;19(2):117-23
pubmed: 17306972
Nano Lett. 2010 Nov 10;10(11):4756-61
pubmed: 20957983
Nat Methods. 2014 Mar;11(3):313-8
pubmed: 24487583
Histochem Cell Biol. 2014 Jun;141(6):629-38
pubmed: 24522395
Nat Struct Mol Biol. 2011 Oct 23;18(11):1244-9
pubmed: 22020299
Expert Opin Ther Targets. 2012 Jan;16(1):15-31
pubmed: 22239438
Trends Cell Biol. 2009 Oct;19(10):542-51
pubmed: 19758803
Nature. 2012 Mar 28;483(7391):603-7
pubmed: 22460905
PLoS One. 2015 Nov 17;10(11):e0143162
pubmed: 26575183
NPJ Syst Biol Appl. 2017 Sep 20;3:27
pubmed: 28944080
Ther Adv Urol. 2018 Jan 09;10(3):109-123
pubmed: 29662541
Cell. 2010 Jun 25;141(7):1117-34
pubmed: 20602996
Histochem Cell Biol. 2012 Jan;137(1):1-10
pubmed: 22086768
Clin Cancer Res. 2006 Oct 1;12(19):5764-9
pubmed: 17020982
Sci Rep. 2017 Sep 22;7(1):12150
pubmed: 28939861
Cold Spring Harb Perspect Biol. 2013 May 01;5(5):a017459
pubmed: 23637288
Nat Methods. 2016 May;13(5):439-42
pubmed: 27018580
Br J Cancer. 2011 Sep 6;105(6):807-13
pubmed: 21847121
Biophys J. 2010 Aug 9;99(4):1303-10
pubmed: 20713016
Ann Oncol. 2015 Sep;26(9):1877-1883
pubmed: 26141208
J Clin Oncol. 2011 Dec 20;29(36):4803-10
pubmed: 22042947
Lancet Oncol. 2011 Feb;12(2):175-80
pubmed: 21277552
Nature. 2001 May 17;411(6835):355-65
pubmed: 11357143
Science. 2017 May 26;356(6340):
pubmed: 28495876
J Biol Methods. 2014;1(2):
pubmed: 25606571
Chronic Dis Transl Med. 2017 Jul 19;3(3):148-153
pubmed: 29063069
Cancer Biol Ther. 2007 Apr;6(4):561-70
pubmed: 17495520
Cell. 2000 Oct 13;103(2):211-25
pubmed: 11057895
Biochemistry. 2006 May 23;45(20):6241-51
pubmed: 16700535
Eur Respir Rev. 2010 Sep;19(117):186-96
pubmed: 20956191
Nat Protoc. 2017 Jun;12(6):1198-1228
pubmed: 28518172
Nat Methods. 2018 Sep;15(9):685-688
pubmed: 30127504
Cancer Discov. 2012 Oct;2(10):872-5
pubmed: 23071030
Nat Cell Biol. 2012 Oct;14(10):1057-67
pubmed: 23023225
Clin Cancer Res. 2006 Nov 1;12(21):6494-501
pubmed: 17085664
J Biol Chem. 2000 Mar 24;275(12):8806-11
pubmed: 10722725
FEBS Open Bio. 2017 Aug 29;7(9):1422-1440
pubmed: 28904870
J Microsc. 2006 Dec;224(Pt 3):213-32
pubmed: 17210054
Science. 2007 May 18;316(5827):1039-43
pubmed: 17463250
Proc Natl Acad Sci U S A. 2008 Jan 15;105(2):692-7
pubmed: 18180459
J Thorac Oncol. 2017 Jan;12(1):15-26
pubmed: 27794501
Science. 2020 Feb 7;367(6478):643-652
pubmed: 32029621
Oncotarget. 2015 Oct 13;6(31):30929-38
pubmed: 26439803